Chunli Wu

Dr. Chunli Wu

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMaxwell Ampomah-Wireko
Maxwell Ampomah-Wireko
CLChunying Luo
Chunying Luo
YCYaquan Cao
Yaquan Cao
HWHuanhuan Wang
Huanhuan Wang
LNLauraine Nininahazwe
Lauraine Nininahazwe
CWChunli Wu
Chunli Wu

14 March 2017 in Molecules
Verified
Journal Article
Open access
PDF file
DJDanielle D. Jandial
Danielle D. Jandial
LKLauren S. Krill
Lauren S. Krill
LCLixia Chen
Lixia Chen
CWChunli Wu
Chunli Wu
YKYu Ke
Yu Ke
XZXiaolin Zi
Xiaolin Zi
HER2/neu positive breast tumors predict a high mortality and comprise 25%–30% of breast cancer. We have shown that Flavokawain A (FKA) preferentially reduces the viabilities of HER2-overexpressing breast cancer cell lines (i.e., SKBR3 and MCF7/HER2) versus those with less HER2 expression (i.e., MCF7 and MDA-MB-468). FKA at cytotoxic concentrations to breast cancer cell lines also has a minimal effect on the growth of non-malignant breast epithelial MCF10A cells. FKA induces G2M arrest in cell cycle progression of HER2-overexpressing breast cancer cell lines through inhibition of Cdc2 and Cdc25C phosphorylation and downregulation of expression of Myt1 and Wee1 leading to increased Cdc2 kinase activities. In addition, FKA induces apoptosis in SKBR3 cells by increasing the protein expression of Bim and BAX and decreasing expression of Bcl2, BclX/L, XIAP, and survivin. FKA also downregulates the protein expression of HER-2 and inhibits AKT phosphorylation. Herceptin plus FKA treatment leads to an enhanced growth inhibitory effect on HER-2 overexpressing breast cancer cell lines through downregulation of Myt1, Wee1, Skp2, survivin, and XIAP. Our results suggest FKA as a promising and novel apoptosis inducer and G2 blocking agent that, in combination with Herceptin, enhances for the treatment of HER2-overexpressing breast cancer.

25 November 2020 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
YCYaquan Cao
Yaquan Cao
CLChunying Luo
Chunying Luo
PYPu Yang
Pu Yang
PLPan Li
Pan Li
CWChunli Wu
Chunli Wu

30 October 2024 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAichata Maiga
Aichata Maiga
MAMaxwell Ampomah-Wireko
Maxwell Ampomah-Wireko
HLHongteng Li
Hongteng Li
ZFZhengmin Fan
Zhengmin Fan
ZLZiwei Lin
Ziwei Lin
CWChunli Wu
Chunli Wu

2 October 2017 in Polymers
Verified
Journal Article
Open access
PDF file
CWChunli Wu
Chunli Wu
XLXueming Li
Xueming Li
SSSiyu Song
Siyu Song
YPYuxin Pei
Yuxin Pei
LGLili Guo
Lili Guo
ZPZhichao Pei
Zhichao Pei
A quartz crystal microbalance (QCM) biosensor based on polydopamine (PDA) surface was developed for real-time analysis of the binding kinetics of protein-protein interactions. The biosensor was fabricated by simply immersing the gold sensor chip into an aqueous dopamine solution at pH 8.5 leading to a spontaneous deposition of PDA film onto the sensor chip surface, which was followed by incubation with the protein to immobilize it onto the PDA-coated sensor chip surface via Michael addition and/or Schiff base reactions. In this paper, the interaction between monoclonal anti-myoglobin 7005 antibody (IgG1) and its antigen human cardiac myoglobin was used as a model system for real-time analysis of biomolecule interactions on the biosensor surface. The kinetic parameters of the interaction between anti-myoglobin 7005 and myoglobin were studied on the biosensor surface, which were consistent with the results obtained via amine coupling. The biosensor based on PDA surface has excellent regenerability, reproducibility, and specificity. Compared with the most frequently/typically used amine coupling method for immobilization of proteins on carboxylated substrates, the modification methodology presented in this paper is simple, mild and is not subjected to the limitations of the isoelectric point (pI) of the protein. In addition, the PDA biosensor chip can be easily reused, which makes QCM biosensor analysis more efficient and cost effective.

5 March 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
YCYaquan Cao
Yaquan Cao
YYYingxue Yang
Yingxue Yang
MAMaxwell Ampomah-Wireko
Maxwell Ampomah-Wireko
FFFiras Obaid Arhema Frejat
Firas Obaid Arhema Frejat
HZHongjin Zhai
Hongjin Zhai
CWChunli Wu
Chunli Wu